UKUmair Kamran

Umair Kamran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Umair Kamran has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reverse rendezvous endoscopic retrograde cholangiopancreatography after liver partition and portal vein ligation

    by Khurum Hakeem, Eoin Keating, Khalid Bashir, Umair Kamran, Yiannis Skarparis, Dhya Al-Leswas, John Leeds

    A 45-year-old-man was diagnosed with primary rectal cancer during colonoscopy. Despite the initial disease response to neoadjuvant chemotherapy, imaging demonstrated progression of the right hepatic metastatic disease. Associated liver partition and portal ligation surgery (ALPPS) was planned. Stage 1 ALPPS was successful but extended hepatectomy and stage 2 ALPPS was complicated by a liver remnant anchor failure requiring repeat surgical intervention. High outputs from the right liver bed drain and cross-sectional imaging identified a liver bed bile leak secondary to a left hepatic duct stricture. Conventional endoscopic retrograde cholangiopancreatography (ERCP) was unable to access the intrahepatic system due a blind-ending proximal common bile duct (CBD).[1] Subsequent percutaneous transhepatic cholangiography (PTC) drainage accessed the left intrahepatic duct but could not traverse the stricture to the CBD. Multidisciplinary team discussion recommended a “reverse-rendezvous ERCP” to attempt internal drainage ([Video 1]).[2] [3] Initial CBD cannulation and pressure cholangiograms demonstrated persistent occlusion of the proximal CBD. Anterograde cholangiogram via the PTC demonstrated no communication of the intrahepatic ducts with the CBD, with a transition zone at the left hepatic duct. Video 1 Reverse rendezvous ERCP for postoperative bile leak after ALPPS. Endoscopic and percutaneous guidewires were advanced into the liver bed collection, creating through-and-through access from the ampulla to the left intrahepatic ducts. Following balloon dilatation, a plastic stent was placed for internal drainage, with contrast confirming flow into the duodenum. Endoscopic wire manipulation and occlusion cholangiography successfully accessed the left liver bed collection. Simultaneous percutaneous guidewire manipulation resulted in both wires entering the collection. A snare was deployed via the PTC and captured the endoscopic guidewire. This created a through-and-through guidewire crossing the ampulla, traversing the left intrahepatic duct and exiting the PTC site ([Fig. 1]). The tract was dilated by a 6 mm dilatation balloon. A 10 French×15 cm straight plastic stent was deployed entering the left intrahepatic ductal system. A PTC drain was deployed “kissing” the proximal CBD stent. PTC contrast injection demonstrated flow entering the duodenum. Four weeks following the initial rendezvous procedure, the drain was successfully internalised via the mature tract. This case represents the first published “reverse-rendezvouz ERCP” in a patient with unique post-operative biliary anatomy. Endoscopy_UCTN_Code_CPL_1AK_2AD. Received: 30 March 2026 Accepted after revision: 28 May 2026 Article published online: 13 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Open Access

    Differences in Endoscopy Characteristics Between Providers With the Highest and Lowest Post Endoscopy Upper Gastrointestinal Cancer Rates in England

    by Umair Kamran, Felicity Evison, Eva J. A. Morris, Matthew Brookes, Matt Rutter, David Beaton, Mimi McCord, Nicola J. Adderley, Nigel Trudgill

    Background: Post‐endoscopy upper gastrointestinal cancer (PEUGIC) rates vary over threefold between endoscopy providers in England. To determine if variations in endoscopy characteristics contribute, providers with the lowest and highest PEUGIC rates were compared. Methods: Endoscopy providers were categorized into quartiles based on PEUGIC rates and those in the highest and lowest quartiles studied. Data for diagnostic upper gastrointestinal (UGI) endoscopy performed between January 2019 and February 2020 were extracted from the National Endoscopy Database. Multivariable regression analysis explored the endoscopy characteristics associated with the lowest PEUGIC rate providers after adjusting for patient characteristics and indications. Results: In total, 328,354 diagnostic UGI endoscopy performed by 54 providers were included. Endoscopy characteristics positively associated with the lowest PEUGIC rate providers included: training sessions (Odds Ratio 1.85 (95% CI 1.81–1.90)); intravenous sedation use (1.09 (1.07–1.11)); endoscopist average UGI endoscopy annual volume 101–200 (1.05 (1.02–1.07) and 201–300 (1.16 (1.13–1.19)). Endoscopy characteristics inversely associated with the lowest PEUGIC rate providers included: endoscopy half‐day sessions with average ≥ 9 points (0.72 (0.71–0.74)); endoscopists not on nursing, specialty or trainee register (0.83 (0.81–0.85)); and biopsies during endoscopy (0.84 (0.83–0.86)). Compliance with national quality standards to biopsy high risk conditions was better in providers with the lowest PEUGIC rates. Discussion: Training sessions, more endoscopists with minimum annual endoscopy volumes > 100, more intravenous sedation, less biopsies and lower intensity endoscopy sessions were associated with the lowest PEUGIC rate providers. These findings may help guide efforts to reduce PEUGIC and improve endoscopy quality in the future.


  • Open Access

    All-cause mortality, adverse events and associated factors following endoscopic retrograde cholangiopancreatography for benign indications in England

    by Umair Kamran, Philip R. Harvey, Ben Coupland, Jemma Mytton, Kofi W. Oppong, Nigel Trudgill

    Population-based data on outcomes of endoscopic retrograde cholangiopancreatography (ERCP) for benign indications are limited. We examined the impact of changing patient demographics on ERCP outcomes. Adults undergoing first ERCP for benign indications between 2003 and 2020 in England were identified in Hospital Episode Statistics. All-cause mortality within 30 days and adverse event rates within 7 days were calculated. Multivariable logistic regression analysis explored factors associated with all-cause mortality. A total of 283,972 patients were included; 63.4% female; median age 67 years (interquartile range 50–79). Twenty-five percent of ERCPs in 2019/2020 were performed in patients with a Charlson comorbidity score ≥ 5, compared with 8% in 2003/2004. Three percent of patients who underwent day case ERCP had an emergency readmission with pancreatitis. Thirty-day all-cause mortality fell by 31% over the study period. Mortality was associated with age (age quintile ≥ 82 years; odds ratio 19.22; 95% confidence interval [CI] 15.59–23.69 compared with 18–46 years), male sex (1.21; CI 1.14–1.27), Black or Black British ethnicity (1.42; CI 1.07–1.90), increasing comorbidity score ≥ 5 (3.35; CI 3.14–3.57), and increasing provider annual ERCP volume (volume ≥ 151; 1.08; CI 1.01–1.16). Elective ERCP (0.30; CI 0.28–0.33) and those in recent years were associated with lower mortality (2019/2020 compared with 2003/2004 (0.40; CI 0.34–0.48). Statistically significant variations in 30-day all-cause mortality were observed between ERCP providers. Despite the increasing age and comorbidities of patients undergoing ERCP for benign indications, 30-day all-cause mortality fell by 31% in recent years. All-cause mortality was associated with age, males, comorbidities, black ethnicity, emergency ERCP, and increasing provider volume.

  • Open Access

    The variation in post-endoscopy upper gastrointestinal cancer rates among endoscopy providers in England and associated factors: a population-based study

    by Umair Kamran, Felicity Evison, Eva Judith Ann Morris, Matthew J Brookes, Matthew David Rutter, Mimi McCord, Nicola J Adderley, Nigel Trudgill

    Background Post-endoscopy upper gastrointestinal cancer (PEUGIC) is an important key performance indicator for endoscopy quality. We examined variation in PEUGIC rates among endoscopy providers in England and explored associated factors. Methods The was a population-based, retrospective, case–control study, examining data from National Cancer Registration and Analysis Service and Hospital Episode Statistics databases for esophageal and gastric cancers diagnosed between 2009 and 2018 in England. PEUGIC were cancers diagnosed 6 to 36 months after an endoscopy that did not diagnose cancer. Associated factors were identified using multivariable logistic regression analyses. Results The national PEUGIC rate was 8.5%, varying from 5% to 13% among endoscopy providers. Factors associated with PEUGIC included: female sex (odds ratio [OR] 1.29 [95%CI 1.23–1.36]); younger age (age >80 years, OR 0.52 [0.48–0.56], compared with ≤60 years); increasing comorbidity (Charlson score >4, OR 5.06 [4.45–5.76]); history of esophageal ulcer (OR 3.30 [3.11–3.50]), Barrett’s esophagus (OR 3.21 [3.02–3.42]), esophageal stricture (OR 1.28 [1.20–1.37]), or gastric ulcer (OR 1.55 [1.44–1.66]); squamous cell carcinoma (OR 1.50 [1.39–1.61]); and UK national endoscopy accreditation status – providers requiring improvement (OR 1.10 [1.01–1.20]), providers never assessed (OR 1.24 [1.04–1.47]). Conclusion PEUGIC rates varied threefold among endoscopy providers, suggesting unwarranted differences in endoscopy quality. PEUGIC was associated with endoscopy findings known to be associated with upper gastrointestinal cancer and a lack of national endoscopy provider accreditation. PEUGIC variations suggest an opportunity to raise performance standards to detect upper gastrointestinal cancers earlier and improve outcomes.


  • Open Access

    Umbrella systematic review of potential quality indicators for the detection of dysplasia and cancer at upper gastrointestinal endoscopy

    by Umair Kamran, Abdullah Abbasi, Nosheen Umar, Imran Tahir, Matthew J Brookes, Matt Rutter, Mimi McCord, Nicola J Adderley, Janine Dretzke, Nigel Trudgill

    Background and study aims Upper gastrointestinal (UGI) endoscopy lacks established quality indicators. We conducted an umbrella systematic review of potential quality indicators for the detection of UGI cancer and dysplasia. Methods Bibliographic databases were searched up to December 2021 for systematic reviews and primary studies. Studies reporting diagnostic accuracy, detection rates or the association of endoscopy or endoscopist-related factors with UGI cancer or dysplasia detection were included. AMSTAR2 and JBI checklists were used to assess systematic review and primary study quality. Clinical heterogeneity precluded meta-analysis and findings are summarized narratively. Results Eight systematic reviews and nine primary studies were included. Image enhancement, especially narrow band imaging, had high diagnostic accuracy for dysplasia and early gastric cancer (pooled sensitivity 0.87 (95% CI 0.84–0.89) and specificity 0.97 (0.97–0.98)). Higher detection rates with longer endoscopy examination times were reported in three studies, but no difference was observed in one study. Endoscopist biopsy rate was associated with increased gastric cancer detection (odds ratio 2.5; 95% confidence interval [CI] 2.1–2.9). Early esophageal cancer (0.17% vs 0.14%, P=0.04) and gastric cancer (0.16% vs 0.12%, P=0.02) detection rates were higher with propofol sedation compared to no sedation. Endoscopies performed by trained endoscopists on dedicated Barrett’s surveillance lists had higher detection rates (8% vs 3%, P<0.001). The neoplasia detection rate during diagnostic endoscopies for Barrett’s esophagus was 7% (95% CI 4%-10%). Conclusions Image enhancement use, longer examination times, biopsy rate and propofol sedation are potential quality indicators for UGI endoscopy. Neoplasia detection rate and dedicated endoscopy lists are additional potential quality indicators for Barrett’s esophagus


  • Open Access

    Complications of diagnostic upper Gastrointestinal endoscopy: common and rare – recognition, assessment and management

    by William Waddingham, Umair Kamran, Bhaskar Kumar, Nigel J Trudgill, Zacharias P Tsiamoulos, Matthew Banks

    A clear understanding of the potential complications or adverse events (AEs) of diagnostic endoscopy is an essential component of being an endoscopist. Creating a culture of safety and prevention of AEs should be part of routine endoscopy practice. Appropriate patient selection for procedures, informed consent, periprocedure risk assessments and a team approach, all contribute to reducing AEs. Early recognition, prompt management and transparent communication with patients are essential for the holistic and optimal management of AEs. In this review, we discuss the complications of diagnostic upper gastrointestinal endoscopy, including their recognition, treatment and prevention.


  • A root cause analysis system to establish the most plausible explanation for post-endoscopy upper gastrointestinal cancer

    by Umair Kamran, Dominic King, Abdullah Abbasi, Ben Coupland, Nosheen Umar, Warren C. Chapman, Srisha Hebbar, Nigel J. Trudgill

    Background Missing upper gastrointestinal cancer (UGIC) at endoscopy may prevent curative treatment. We have developed a root cause analysis system for potentially missed UGICs at endoscopy (post-endoscopy UGIC [PEUGIC]) to establish the most plausible explanations.Methods The electronic records of patients with UGIC at two National Health Service providers were examined. PEUGICs were defined as UGICs diagnosed 6–36 months after an endoscopy that did not diagnose cancer. An algorithm based on the World Endoscopy Organization post-colonoscopy colorectal cancer algorithm was developed to categorize and identify potentially avoidable PEUGICs.Results Of 1327 UGICs studied, 89 (6.7 %) were PEUGICs (patient median [IQR] age at endoscopy 73.5 (63.5–81.0); 60.7 % men). Of the PEUGICs, 40 % were diagnosed in patients with Barrett’s esophagus. PEUGICs were categorized as: A – lesion detected, adequate assessment and decision-making, but PEUGIC occurred (16.9 %); B – lesion detected, inadequate assessment or decision-making (34.8 %); C – possible missed lesion, endoscopy and decision-making adequate (8.9 %); D – possible missed lesion, endoscopy or decision-making inadequate (33.7 %); E – deviated from management pathway but appropriate (5.6 %); F – deviated inappropriately from management pathway (3.4 %). The majority of PEUGICs (71 %) were potentially avoidable and in 45 % the cancer outcome could have been different if it had been diagnosed on the initial endoscopy. There was a negative correlation between endoscopists’ mean annual number of endoscopies and the technically attributable PEUGIC rate (correlation coefficient −0.57; P = 0.004).Conclusion Missed opportunities to avoid PEUGIC were identified in 71 % of cases. Root cause analysis can standardize future investigation of PEUGIC and guide quality improvement efforts.


  • Improving 30-day mortality after PEG tube placement in England from 2007 to 2019: a retrospective national cohort analysis of 87,862 patients

    by Umair Kamran, Pui Chi Lee, Ben Coupland, Abdullah Abbasi, Helen Steed, Sissi Ispoglou, Fumi Varyani, Nigel Trudgill


  • Correction: Rate of pancreatic cancer following a negative endoscopic ultrasound and associated factors

    by Dominic King, Umair Kamran, Amandeep Dosanjh, Ben Coupland, Jemma Mytton, John S. Leeds, Manu Nayar, Prashant Patel, Kofi W. Oppong, Nigel J. Trudgill

    * Joint first authors ** Joint senior authors Article published online: 22 June 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • O51 Post EUS pancreatic cancer does it occur and what is the timeframe: the PEPC study

    by Shiran Esmaily, Chia Chuin Yau, John Leeds, Umair Kamran, Nigel Trudgill, Wasfi Alrawashdeh, Gourab Sen, Sanjay Pandanaboyana, Manu Nayar, Kofi Oppong

    Introduction The concept of post endoscopy cancer (PEC) is well established. There are limited studies on post-endoscopic ultrasound pancreatic cancer (PEPC). A recent population level study using hospital episode statistics (HES) from England reported a PEPC rate of 6.5%. In the HES study, in keeping with established PEC methodology, pancreatic cancer (PC) diagnosed within 6 months of EUS was regarded as associated with the index EUS. The timeframe used for PEPC was 6–18 months in recognition of the aggressive nature of the disease. However, it may not be appropriate to associate all PC diagnosis within 6 months with the index EUS. Further detailed studies at unit level are required to delineate the problem and provide a categorisation framework. The aim of this study was to determine the incidence of PEPC in a regional PC centre and time to PEPC diagnosis within 18 months of a non-diagnostic index EUS. Methods Patients registered with PC via the regional MDT between 1/1/2010–31/12/2021 were identified and cross-referenced with patients undergoing EUS between 1/1/2010–31/12/2020. PEPC was defined as PC occurring following index EUS with low suspicion of malignancy. Cases with occurrence of PC within 18 months of index EUS formed the study group. The following criteria was used to filter patients. 1. ≥2 EUS procedures PC diagnosis >6 weeks from EUS Patients with 2nd EUS >2–3 months from previous one Known cases of PEPC during the study period Electronic notes were reviewed for patients meeting filtering criteria. Results 11447 patients had an EUS. 2416 had PC diagnosis at MDT (21.1% PC yield). 1431 patients had both an EUS and MDT diagnosis of PC of which 1302 were within 18 months of index EUS. Following filtering 353 case notes were reviewed. 29/1302 (2.2%) of patients were identified as PEPC, 14 males (48.3%), mean age 64.1 years. Median interval between index EUS and PEPC diagnosis was 5 months. Table 1 details the time course. Conclusion In this study with careful case ascertainment, overall PEPC at 18 months was 2.2%. This is much lower than determined in a recent HES study. However, a timeframe of 6–18 months would have missed the 62% of PEPC cases which occurred within 6 months of index EUS. The time course of PEPC appears more rapid than for other post endoscopy malignancy and may be underestimated if existing PEC methodology is used.